Ekso Bionics Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 3 - Accumulated Other Comprehensive (Loss) Income (Tables)

Note 3 - Accumulated Other Comprehensive (Loss) Income (Tables)

9 Months Ended

Sep. 30, 2025

Notes Tables

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

		*Three Months Ended September 30,*
		*2025*				*2024*
Balance at beginning of period		$	(683	)		$	539
Net unrealized loss on foreign currency translation			(17	)			(527	)
Balance at end of period		$	(700	)		$	12

		*Nine Months Ended September 30,*
		*2025*				*2024*
Balance at beginning of period		$	957			$	156
Net unrealized loss on foreign currency translation			(1,657	)			(144	)
Balance at end of period		$	(700	)		$	12